Cell Membrane‐Camouflaged Chitosan‐Polypyrrole Nanogels Co‐Deliver Drug and Gene for Targeted Chemotherapy and Bone Metastasis Inhibition of Prostate Cancer
Authors:
- 2 May 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (20) , e2400114
Abstract
The development of functional nanoplatforms to improve the chemotherapy outcome and inhibit distal cancer cell metastasis remains an extreme challenge in cancer management. In this work, a human‐derived PC‐3 cancer cell membrane‐camouflaged chitosan‐polypyrrole nanogel (CH‐PPy NG) platform, which can be loaded with chemotherapeutic drug docetaxel (DTX) and RANK siRNA for targeted chemotherapy and gene silencing‐mediated metastasis inhibition of late‐stage prostate cancer in a mouse model, is reported. The prepared NGs with a size of 155.8 nm show good biocompatibility, pH‐responsive drug release profile, and homologous targeting specificity to cancer cells, allowing for efficient and precise drug/gene co‐delivery. Through in‐vivo antitumor treatment in a xenografted PC‐3 mouse tumor model, it is shown that such a CH‐PPy NG‐facilitated co‐delivery system allows for effective chemotherapy to slow down the tumor growth rate, and effectively inhibits the metastasis of prostate cancer to the bone via downregulation of the RANK/RANKL signaling pathway. The created CH‐Ppy NGs may be utilized as a promising platform for enhanced chemotherapy and anti‐metastasis treatment of prostate cancer.Keywords
Funding Information
- National Natural Science Foundation of China (52350710203, U23A2096, 82172809)
- Science and Technology Commission of Shanghai Municipality (21490711500, 23WZ2503300, 23520712500, 20DZ2254900)
- King Saud University (RSPD2024R769)
This publication has 32 references indexed in Scilit:
- Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancerDiscover Oncology, 2023
- Oral delivery of RNAi for cancer therapyCancer and Metastasis Reviews, 2023
- Chemotherapy Mediated by Biomimetic Polymeric Nanoparticles Potentiates Enhanced Tumor Immunotherapy via Amplification of Endoplasmic Reticulum Stress and Mitochondrial DysfunctionAdvanced Materials, 2022
- Emerging Approaches for Enabling RNAi TherapeuticsChemistry – An Asian Journal, 2022
- Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapyBioactive Materials, 2021
- Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma TreatmentAdvanced Materials, 2020
- RANKL/RANK/OPG cytokine receptor system: mRNA expression pattern in BPH, primary and metastatic prostate cancer diseaseWorld Journal of Urology, 2017
- Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancerCancer Letters, 2017
- SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatmentBiomaterials, 2014
- RANK-mediated signaling network and cancer metastasisCancer and Metastasis Reviews, 2014